COMMUNIQUÉS West-GlobeNewswire

Ignite Proteomics Announces Publication of Study Demonstrating Superiority of Protein Activation Analysis in Predicting Breast Cancer Therapy Response

10/02/2025 - 15:15

The new study adds to growing evidence that measuring activated proteins is key to cancer therapy selection. Golden, CO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. ( [...]

Cogent Biosciences Announces Bezuclastinib Poster in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2025 AAAAI Annual Meeting

10/02/2025 - 15:15

WALTHAM, Mass. and BOULDER, Colo., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today [...]

Immix Biopharma Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for NXC-201, sterically-optimized CAR-T for relapsed/refractory AL Amyloidosis

10/02/2025 - 15:35

FDA RMAT designation follows positive proof-of-concept U.S. clinical data from the NXC-201 NEXICART-2 clinical trial in relapsed/refractory AL Amyloidosis RMAT designation potentially streamlines the path to market [...]

Notification of managers' transactions

10/02/2025 - 16:43

ANNOUNCEMENT NO. 288 10 February 2025 Notification of managers’ transactions ChemoMetec A/S has received the enclosed notification pursuant to Article 19 of EU Regulation no. 596/2014 of transactions related to shares [...]

Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol

10/02/2025 - 17:00

Trading Under New Ticker of “EXOZ” Expected to Begin February 12, 2025 Monrovia, CA, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Today, Invizyne Technologies, Inc., (NASDAQ: IZTC) ("Invizyne"), a leading designer of cell-free, [...]

Press Release: Transparency Notification from Shareholders

10/02/2025 - 17:30

Transparency Notification from Shareholders Ghent, Belgium – 10 February 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the treatment of fluid overload in [...]

Compass Health Announces New Recruitment Initiative Showcasing Career Opportunities and Enhanced Benefits

10/02/2025 - 17:34

EVERETT, Wash., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Compass Health, Northwest Washington’s behavioral healthcare leader, has launched a new recruitment initiative aimed at attracting skilled professionals to its mission- [...]

Revolo to Present at the 2025 AAAAI / WAO Joint Congress

10/02/2025 - 18:00

GAITHERSBURG, Md. and CAMBRIDGE, United Kingdom, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics Limited (“Revolo”) today announced that it will present two posters on its lead candidate, ‘1104, at the 2025 [...]

Comprehensive Healthcare Welcomes Addictionologist to Strengthen Substance Use Disorder Care Delivery

10/02/2025 - 18:15

YAKIMA, Wash., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Comprehensive Healthcare recently welcomed its first-ever board-certified addictionologist, Dr. Gillian Zuckerman, as part of the community behavioral health provider’s [...]

Inventiva publie ses résultats financiers préliminaires pour l'exercice fiscal 2024¹ et fait le point sur son activité

10/02/2025 - 22:00

Chiffre d'affaires de 9,2 millions d'euros pour l’année 2024 Trésorerie et équivalents de trésorerie à 96,6 millions d’euros au 31 décembre 2024 Levée de la première tranche d'un financement structuré d'un montant [...]

Inventiva reports preliminary 2024 fiscal year financial results¹ and provides a business update

10/02/2025 - 22:00

Revenues of €9.2 million for the full year of 2024 Cash and cash equivalents at €96.6 million as of December 31, 2024 First tranche of up to €348 million structured financing closed with aggregate gross proceeds of €116 [...]

Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Outlook

10/02/2025 - 22:02

Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024 MINNEAPOLIS, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire [...]

Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

10/02/2025 - 22:03

BOSTON, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by [...]

Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update

10/02/2025 - 22:05

Revenues increased 34% compared to the previous quarter ended September 30, 2024; and exceeded $1 million Received CE Mark for LungFit PH ® in Europe and Market Authorization in Australia; international shipments to [...]

PetMeds® Announces Third Quarter Fiscal 2025 Financial Results

10/02/2025 - 22:05

DELRAY BEACH, Fla., Feb. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its third quarter ended December 31, 2024. [...]

Stryker announces Allan Golston will retire from Board of Directors

10/02/2025 - 22:05

Portage, Michigan, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that after 14 years of distinguished service, Allan Golston has notified the company that he will not stand for re-election at [...]

Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10/02/2025 - 22:44

SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on February 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock [...]

RxTechExam and Pennsylvania Pharmacists Association Join Forces to Launch Technician Training Program Ahead of Regulatory Changes

10/02/2025 - 22:44

HARRISBURG, Pa., Feb. 10, 2025 (GLOBE NEWSWIRE) -- RxTechExam and the Pennsylvania Pharmacists Association (PPA) have announced a strategic partnership aimed at addressing upcoming pharmacy technician regulations in [...]

Alumis to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

10/02/2025 - 22:45

SOUTH SAN FRANCISCO, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes [...]